<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transferrin receptors (TfRs) are the conventional pathway by which cells acquire iron for physiological requirements </plain></SENT>
<SENT sid="1" pm="."><plain>Under iron-deficient conditions there is an increased concentration of surface TfR, especially on bone marrow erythroid precursors, as a mechanism to sequester needed iron </plain></SENT>
<SENT sid="2" pm="."><plain>TfRs are also present in the circulation, and the circulating serum TfR (sTfR) level reflects total body TfR concentration </plain></SENT>
<SENT sid="3" pm="."><plain>Under <z:mpath ids='MPATH_458'>normal</z:mpath> conditions erythroid precursors are the main source of sTfR </plain></SENT>
<SENT sid="4" pm="."><plain>Disorders of the bone marrow with <z:mp ids='MP_0008973'>reduced erythroid precursors</z:mp> are associated with low sTfR levels </plain></SENT>
<SENT sid="5" pm="."><plain>The sTfR concentration begins to rise early in <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> with the <z:hpo ids='HP_0003674'>onset</z:hpo> of iron-deficient erythropoiesis, and continues to rise as iron-deficient erythropoiesis progressively worsens, prior to the development of <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The sTfR level does not increase in <z:hpo ids='HP_0001903'>anemia</z:hpo> of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp>, but is increased when <z:hpo ids='HP_0001903'>anemia</z:hpo> of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> is combined with <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The sTfR level is also increased in patients with expanded erythropoiesis, including <z:hpo ids='HP_0001878'>hemolytic anemias</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, and use of erythropoietic stimulating agents </plain></SENT>
<SENT sid="8" pm="."><plain>The ratio of sTfR/ferritin can be used to quantify the entire spectrum of iron status from positive iron stores through negative iron balance, and is particularly useful in evaluating iron status in population studies </plain></SENT>
<SENT sid="9" pm="."><plain>The sTfR/log ferritin ratio is valuable for distinguishing <z:hpo ids='HP_0001903'>anemia</z:hpo> of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> from <z:hpo ids='HP_0001891'>iron deficiency anemia</z:hpo>, whether the latter occurs alone or in combination with <z:hpo ids='HP_0001903'>anemia</z:hpo> of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>